Survey of midazolam use in non-convulsive seizure emergencies
Treatments studied
Part of Brain & nervous system clinical trials.
This trial is a survey about how midazolam is used in people with non-convulsive status epilepticus, especially when it’s given outside a medical facility and when an extra dose is needed. It may help doctors better understand real-world treatment patterns and safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had non-convulsive status epilepticus (ongoing seizure activity without major shaking).
- You were given the study medication (midazolam) outside a hospital or clinic.
- You received an additional (extra) dose of the study medication.
- You do not have any reason you cannot safely take midazolam (no contraindication).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving ketamine early, before reaching the hospital, can stop prolonged seizures in children with epilepsy. It is for kids who have had at least one seizure emergency in the past year.
This study compares two sedative medicines, remimazolam and midazolam, for people who are on a ventilator and need deep sedation despite unstable blood pressure. The goal is to see which drug is safer and more effective for critically ill patients.
This trial studies the best dose of a seizure medicine for children who are actively seizing while emergency medical teams are treating them. It may help EMS crews give safer, more effective treatment during transport.
This study tests whether ketamine can help stop seizures that haven't responded to standard treatments. It's for people with a serious condition called status epilepticus, where seizures don't stop on their own.
This study checks how a new medicine (NTQ5082) interacts with another drug (midazolam) in healthy volunteers. If you qualify, you'll receive the study medicine and midazolam while being monitored for safety and how the drugs affect each other.
This trial tests a new medicine, currently known by the code LY4355756, in healthy people to check its safety and how the body handles it. Your participation could help show if this medicine is safe enough to move into larger testing.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.